Devgen NV Raises $37 Million In European IPO
10/19/2005 5:08:45 PM
June 8, 2005 Devgen N.V. sold 4 million shares last week at EUR 7.50, at the bottom of the company's proposed range of EUR 7.50-10. The sale resulted in a post-money valuation of slightly more than $127 million (EUR 104 million). Devgen was founded in 1997, as a C. elegans model organism company. It was part of a wave of model organism companies that included such names as Exelixis, DeveloGen AG, and Lexicon Genetics, to name just a few. We look at the focus of the company and its partnerships...
comments powered by